Panevin, T. S., Zotkin, E. G., Troshina, E. A., & Lukina, G. V. (2023). Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations. IMA PRESS LLC.
Chicago Style (17th ed.) CitationPanevin, T. S., E. G. Zotkin, E. A. Troshina, and G. V. Lukina. Rituximab in the Treatment of Graves’ Disease and Endocrine Ophthalmopathy. Opportunities and Limitations. IMA PRESS LLC, 2023.
MLA (9th ed.) CitationPanevin, T. S., et al. Rituximab in the Treatment of Graves’ Disease and Endocrine Ophthalmopathy. Opportunities and Limitations. IMA PRESS LLC, 2023.
Warning: These citations may not always be 100% accurate.